| US 7,501,411 B2 | ||
| Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases | ||
| Martin James Inglis Andrews, Mechelen (Belgium); Paul Edwards, Laval (Canada); Mark Stuart Chambers, Saffron Walden (United Kingdom); Wolfgang Schmidt, Saffron Walden (United Kingdom); Juha Andrew Clase, Mechelen (Belgium); Gregory Bar, Mechelen (Belgium); Kim Louise Hirst, Saffron Walden (United Kingdom); and Angus MacLeod, Saffron Walden (United Kingdom) | ||
| Assigned to Galapagos, NV, Mechelen (Belgium) | ||
| Filed on May 30, 2007, as Appl. No. 11/809,294. | ||
| Claims priority of provisional application 60/932100, filed on May 29, 2007. | ||
| Claims priority of provisional application 60/931763, filed on May 25, 2007. | ||
| Claims priority of provisional application 60/931844, filed on May 25, 2007. | ||
| Claims priority of provisional application 60/931764, filed on May 25, 2007. | ||
| Claims priority of provisional application 60/803552, filed on May 31, 2006. | ||
| Prior Publication US 2008/0090818 A1, Apr. 17, 2008 | ||
| Int. Cl. C07D 487/04 (2006.01); A61K 31/4985 (2006.01) | ||
| U.S. Cl. 514—233.2 [514/249; 544/118; 544/350] | 54 Claims |
1. A compound according to formula III:
![]() wherein
R1 is H, or substituted or unsubstituted alkyl;
R8 is
![]() L is selected from a single bond, alkylene, —O—, —N(R8e)—, —CO—, —CO2—, —SO—, —SO2—, —CON(R8e)—, —SO2N(R8e)—, —N(R8e)CO—, —N(R8e)SO2—, —N(R8e)CO N(R8e)—, —N(R8e)SO2 N(R8e)—; —O(CR8e2)m1—, or —CON(R8e)(CR8e2)m1—;
each R8a is independently selected from hydrogen, substituted or unsubstituted alkyl, alkoxy, cyano, and halo;
R8d is selected from substituted or unsubstituted heterocycloalkyl;
R8e is selected from H, substituted or unsubstituted alkyl and substituted or unsubstituted cycloalkyl;
the subscript m1 is 1, 2, 3, or 4; the subscript n is 1, 2, 3, or 4;
and R9 is independently selected from substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted
or unsubstituted aryl, substituted or unsubstituted heteroaryl; or a pharmaceutically acceptable salt thereof; and stereoisomers
and tautomers thereof.
|